19 September 2019 | September 2019 BRACE award competition | AFCR webpage
EDDC project on ETC-159 awarded winner at the first ever BRACE Award Venture Competition
The A*STAR Experimental Drug Development Centre’s (EDDC) project on ETC-159, a novel small molecule drug candidate for colorectal cancer and other solid tumours was selected as the winner of the inaugural Bridging Research from Academia to Cancer Entrepreneurship (BRACE) competition in September 2019. The project was presented by EDDC Chief Development Officer, Dr Joel Leong. This competition was launched by the Asian Fund for Cancer Research (AFCR), a non-profit organisation committed to curing cancers that have significant impact on Asian populations. Click here to find out more about the 2019 BRACE competition.
26 June 2019 | National platform launched to boost Singapore’s drug development efforts | A*STAR Publicity Highlights
Official opening ceremony of EDDC
On 26 June, Mr Heng Swee Keat, Deputy Prime Minister and Minister for Finance, and Chairman of the National Research Foundation (NRF) officially opened the Experimental Drug Development Centre (EDDC), a national platform for drug discovery and development to channel high potential drug candidates toward commercial and clinical outcomes. The new centre integrates A*STARs Experimental Therapeutics Centre (ETC), the Drug, Discovery and Development (D3) unit, and the Experimental Biotherapeutics Centre (EBC) and will build on the combined capabilities we have developed over the years to support our partners in efforts to discover and develop innovative medicines. Click here to read the full article.